Financial Inflection Point Acquisition Corp. VIII Announces Pricing of $250 Million Initial Public Offering August 28, 2026
Biotech HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma August 28, 2026
Mining Brixton Metals Announces Closing Of Final Tranche Of Private Placement For Aggregate Gross Proceeds Of $9.1 Million August 28, 2026
Financial INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metropolitan Bank Holding Corp.- MCB August 28, 2026
Financial INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rollins, Inc. – ROL August 28, 2026